Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2Fx1QPGHYv0C2ErkZSpAxdeVYHI_w.uncropped.jpg&w=3840&q=75)
Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoChange DetectedThe study has expanded to 147 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.SummaryDifference0.3%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check23 days agoChange DetectedAn erratum has been added to the article regarding Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment, published in Lancet in 2017.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.4 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.4, indicating a recent revision in the content of the web page.SummaryDifference0.1%
Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.